Medtronic is launching its Talent™ thoracic stent graft in the United States that features the new Xcelerant system for placement of the device.
Recently approved by the FDA, the Talent Thoracic Stent Graft with the Xcelerant Delivery System is now available to physicians across the United States and expands the applicability of thoracic aortic repair (TEVAR) to more patients with thoracic aortic aneurysms.
The unique features of the Xcelerant Delivery System and the Talent Thoracic Stent Graft provide meaningful benefits to both physician and patient: a wide range of sizes so more patients can be treated; improved trackability and controlled deployment for easier and more accurate stent graft placement; and high radial force as shown in competitive bench testing.
Press release: Medtronic Launches New Medical Device that Improves Minimally-Invasive Treatment of Thoracic Aortic Aneurysms
Product page: Talent Thoracic Stent Graft…;
Flashbacks: Talent Thoracic Stent Graft System Approved in US ; FDA OK’s Endovascular Talent Stent for AAAs; Talent Thoracic Stent Graft System; Talent Thoracic Stent Graft System